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ABSTRACT 
In the view of the relationships between excessive sodium intake, immunity and target organ 
damage, we hypothesized that reduction in dietary sodium would be beneficial in the 
prevention of cardiac alterations through a restrained local immunity response in a rat model 
of metabolic syndrome. Sprague-Dawley rats were fed a 60% fructose diet with either a 
normal sodium (0.64% NaCl) or a low sodium content (<0.01% NaCl) for 8 weeks. After 4 
weeks, rats were infused or not with angiotensin II (200 ng.kg
-1
.min
-1
, sc) for 4 weeks. Tail-
cuff blood pressure was determined in conscious rats. Heart and left ventricle weight, 
cardiomyocyte size, and cardiac fibrosis were evaluated. We performed a transcriptomic 
analysis in order to identify differentially regulated cardiac mRNAs between normal and low 
sodium diets. We validated those results using qPCR and immunohistochemistry. 
Angiotensin II-induced blood pressure rise was blunted ( 50%) in the low-sodium fed rats 
while cardiac hypertrophy and fibrosis were prevented. Transcriptomic analysis revealed 66 
differentially regulated genes including 13 downregulated genes under the low sodium diet 
and implicated in the innate immune response. This was confirmed by reduced cardiac 
macrophages infiltration under the low sodium diet.  
Dietary sodium restriction prevents structural alterations of the heart of rats with fructose-
induced insulin resistance and angiotensin II-hypertension. The reduction of cardiac 
inflammation and macrophage infiltration suggests that innate immunity has an important role 
in the beneficial effect of sodium restriction on cardiac remodeling. 
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1. INTRODUCTION 
The metabolic syndrome is defined as a cluster of hemodynamic and metabolic abnormalities 
[1,2] associated with an increased risk for development of cardiovascular disease, and insulin 
resistance as a key factor [3,4]. Excessive dietary fructose consumption contributes to obesity 
in humans [5] and to insulin resistance in rodents [6]. In the rat model, a high fructose diet is 
associated with abnormal myocardial architecture [7] and cardiac hypertrophy [8] a 
preclinical disease strongly predictive of cardiovascular morbidity and mortality [9]. In 
humans [10], insulin resistance is associated with an increase in cardiac collagen content and 
diastolic dysfunction. Similar alterations are present in the heart of hypertensive patients [11]
 
and rats [12]. In addition, enhanced angiotensin II and insulin resistance interact in the 
development of cardiovascular disease [13]. Reduction of left ventricular mass was reported 
to improve the risk of subsequent complications [14] and can be achieved with non-
pharmacological maneuvers including a reduction in dietary sodium. Cardiac remodeling was 
obliterated by dietary sodium restriction in various models of hypertension [15,16,17] as well 
as in hypertensive patients [18]. Moreover, the beneficial effect of sodium reduction on the 
heart was reported in insulin resistance [17] and in a new model of metabolic syndrome, the 
DahlS.Z-Lepr
fa
/Lepr
fa
 rat [19], an effect involving a reduction of oxidative stress
 
[15,16,17]. 
 
In insulin resistance, inflammatory cells infiltrate the heart [20] and cardiac mRNA 
expression of inflammation factors are enhanced [21], and macrophages are a major source of 
proinflammatory cytokines, such as TNF-, IL-6 and IL1-β [22]. In hypertension, 
inflammatory signals are released through monocytes and the recruitment of lymphocytes into 
cardiac tissue initiates the fibrosis cascade [10]. Adaptive immunity is also involved in 
cardiac remodeling, as demonstrated by the blunting of the deleterious effects of Angiotensin 
II (AngII)-induced hypertension in immune deficient RAG-1
-/- 
[23] and SCID [24] mice. We 
previously reported that sodium restriction reduced macrophage infiltration and the levels of 
TNF- and IL-6 in the kidney and adipose tissue of the fructose fed rat [25]. Therefore, in 
insulin resistance as in hypertension, innate immunity participates in organ damage, and its 
modulation may explain the beneficial effect of the nutritional intervention. Yet, the 
implication of immunity deserves further investigation in the context of hypertension, insulin 
resistance and more widely of metabolic syndrome [26]. 
 
In the present study, we hypothesized that local innate immune response accompanies the 
beneficial effect of dietary sodium restriction on cardiac alterations in a rat model of 
metabolic syndrome that mimics the human situation [5]. Rats fed a high fructose diet were 
chronically infused with AngII to induce a clear hypertension, superimposed to insulin 
resistance. We performed a transcriptomic analysis on left ventricles to evaluate the influence 
of dietary sodium withdrawal. 
 
2. METHODS 
Full description of experimental procedures is available in Materials and Methods in the 
online-only Data Supplement. Two groups of 40 male Sprague-Dawley rats were fed for 8 
weeks a 60% fructose diet with either a normal sodium (NS: 0.64% NaCl) or a low sodium 
content (LS: <0.01% NaCl). After four weeks, twenty rats from each regimen were infused 
subcutaneously with angiotensin II (AngII, 200 ng.kg
-1
.min
-1
) for the remaining four weeks.  
The statistical evaluation was performed using two-factor analysis of variance (ANOVA) and 
post hoc comparisons were performed by means of Fisher’s Protected Least Significant 
Differences (PLSD) test. If the data were not normally distributed, statistical evaluation was 
performed by using ANOVA (Kruskall-Wallis) and Mann-Whitney U test. Differences were 
considered significant when p< 0.05. 
For transcriptomic analysis, statistical analysis was performed using R software version 3.3.0 
along with the Limma package. The method used for background correction was based on the 
normal-exponential convolution model with the saddle-point approximation to maximum 
likelihood. Normalization was performed using cyclic loess method. Only probes whose 
signal was considered as higher than background in at least four out of six replicates in at least 
one condition were selected for further analysis. Within-array replicate probes were replaced 
with their average. The assessment of differentially expressed mRNAs between NS diet and 
LS diet was performed using the Limma GLM (Generalized Linear Model) method followed 
by Benjamini Hochberg correction for multiple testing. Genes with a corrected p-value lower 
than 0.1 were selected for further investigation.   
 
3. RESULTS 
3.1 Low sodium diet influences metabolic parameters 
After four weeks of fructose regimen, i.e. before AngII infusion, body weight was 
significantly lower in rats submitted to dietary sodium restriction (p=0.0003). This effect of 
low sodium persisted during the four next weeks on AngII infusion. Yet, body weight gain 
and final body weight were similar between hypertensive and normotensive rats on the same 
diet (Table 1). Food intake was significantly lower (by 10-12%) in both LS groups compared 
to control NS groups (Table 1). Fasting plasma glucose was not significantly different 
between groups (Table 1). The response to insulin injection induced a large fall in blood 
glucose in all rats. However, plasma glucose and AUC decreased to a larger extent in control 
LS fructose rats compared to the three other groups, which were not different from each other 
(Supplementary data, Figure S1). 
 3.2 Low sodium diet influences cardiovascular parameters 
Before AngII-infusion, i.e. after 4 weeks on the fructose diet, systolic tail-cuff pressure was 
similar in rats on the NS and LS diet (Figure 1A). As expected, AngII led to an important rise 
in blood pressure that was significantly reduced in the LS compared to the NS fed group 
(Figure 1B, percent change of 22±3 vs 41±4%, respectively). 
 
3.3 Cardiac morphological and histological alterations are prevented by low sodium diet. 
As expected, heart weight and left ventricle weight as well as HW index (HWI) and left 
ventricle weight index were significantly higher in rats infused with AngII (Table 1). Yet, the 
effect of AngII was significantly less marked in LS rats (5-6% increase) compared to rats on 
NS diet (18-24%). Similarly, cardiomyocyte size was significantly smaller in AngII-infused, 
LS fructose rats compared to their NS counterparts (Figure 1C). When the linear relationship 
between body weight and heart weight was examined, the steepening of the slope in AngII, 
NS fructose rats was prevented in LS rats (Figure 1D). 
Sirius red area staining of cardiac tissue was not significantly different in LS vs. NS fructose 
control groups (4.8±0.9 vs 3.9±0.7%, Figure 1E). AngII infusion was associated with a larger 
stained area in rats fed the NS but not LS diet (6.5±1.2 vs 4.97±0.8%). Cardiac mRNA 
expression of TGF-β and SMAD2 were significantly reduced in LS Fructose rats compared to 
the respective NS Fructose rats infused or not with AngII (Figure 1F).  
 
3.4 Transcriptomic analysis of cardiac tissue from NS and LS rats 
To identify genes involved in the prevention of cardiac alterations under the LS diet, we 
compared transcriptomes based on the sodium criteria, i.e. from LS and NS (n=6 in each) left 
ventricles using microarrays. Following data processing and statistical analysis, we obtained a 
list of 66 transcripts differentially regulated (21 upregulated, 45 downregulated) between NS 
and LS rats. We subjected this list to Gene Ontology (GO) classification and enrichment 
analysis, which describes genes in terms of their associated biological processes, molecular 
function and cellular component. In figure 2, we show the classification in terms of biological 
process with fold enrichment when significant. Genes implicated in localization, transport, 
development process, immune system process, adhesion, vesicle-mediated transport, 
morphogenesis, exocytosis, regulation of liquid surface tension, vasoconstriction, were 
significantly enriched. 
Although other genes within the 66 up- or down-regulated could be of interest, we focused on 
genes belonging to the immune system process. GO analysis classified 11 genes in the 
immune system process, which represented a significant fold enrichment of 2.38 with a p 
value of 0.0059. After reviewing the literature, 3 candidate genes were not retained for further 
analysis (Cd248, Col4a1 and Lphn1) and 5 genes were added to the list as they appeared 
relevant to the immune system process (C1qtnf6, C1qtnf9, Hamp, Fcgr3, Tlr2). These final 13 
genes are shown in table 2 and box plot representing microarrays results for each gene are 
shown in figure S2. Interestingly, all transcripts were downregulated upon LS diet.  
 
3.5 Validation of expression variations by qPCR and western blotting 
Overall, there was a good correlation (r²=0.73) between the expression levels detected with 
microarrays and quantitative PCR (Table 2 and data not shown). On the 13 targets evaluated, 
all but 3 (Tlr2, C1qtnf6 and Tpo) were confirmed by qPCR regarding the direction of change 
(downregulation) and statistical significance (p<0.05). Quantitative PCR analysis also 
confirmed low range expression variations, varying between -1.17 (Fes) and -2.86 (Hamp). 
Altogether these results show a global downregulation of these immune transcripts linked to 
cardiac protection induced by salt restriction. The lower expression of Aif1, S100a11 and 
Hamp was also validated at the protein level by immunoblot (Figure S3). 
 
3.6 Macrophage infiltration into cardiac tissue is prevented by the LS diet 
To confirm microarrays and qPCR results at a functional level, we performed 
immunohistochemistry on left ventricles from the 4 groups of rats. Macrophage infiltration, as 
evidenced by CD68-positive cells, was enhanced in NS Fructose animals infused with AngII 
compared with control NS Fructose rats. Interestingly, macrophage infiltration was prevented 
in LS Fructose rats in both control and AngII-infused groups (Figure 3A). Moreover, cardiac 
mRNA expression of CD68 and CD11b, two additional macrophages markers, were 
significantly reduced in control and AngII-infused rats fed the LS diet (Figure 3B). This was 
correlated with reduced expression of EMR1 in LS rats (Table 2). We also evaluated cardiac 
expression of the inflammatory related genes CCL2 (MCP1), a transcript coding for a C-C 
chemokine involved in macrophage tissue recruitment in inflammatory sites, and its cell 
surface receptor, CCR2. Cardiac expression of CCR2 was unmodified by sodium restriction, 
whereas CCL2 expression was significantly reduced in rats fed with LS diet (Figure 3C). 
Similarly, TNF- and RELA expressions were lower in the heart of LS rats (Figure 3C)  
 
4. DISCUSSION 
In the present study, dietary sodium restriction prevents structural alterations of the heart of 
rats with combined insulin resistance and hypertension. We previously reported that reduction 
of dietary salt was able to prevent cardiac hypertrophy in AngII-hypertension [27] as well as 
in insulin resistance associated with high fructose feeding [17]. Reduction of cardiac mass 
may be related to the concomitant lowering of body growth occurring during low sodium 
feeding. In our previous study in fructose-fed rats [17], the effect of low sodium diet was 
clearer on the slope of the relationship between body and heart weight. In the current 
experiments, the steepening of the slope induced by AngII was totally prevented by sodium 
withdrawal. Therefore, body weight difference and body growth had probably only a minor 
influence on the prevention of cardiac hypertrophy. Blunting of hypertension may also 
explain the effect of low sodium diet on cardiac mass. However, the cardiac hypertrophy 
appeared to be independent of afterload in this animal model [28], suggesting that other 
mechanisms have a preeminent role in cardiac protection. 
 
Associated with hypertrophy, fibrosis is another structural alteration of cardiac tissue in 
insulin resistance [8] and hypertension [29]. Dietary sodium restriction had a preventive effect 
on cardiac fibrosis associated with AngII infusion, while no obvious effect was detected in 
control normotensive fructose rats. Among the signals that promote fibrosis, TGF-β has a 
pivotal role by activating myofibroblasts and producing collagen [30] and particularly 
collagen type I alpha 2 (COL1A2) [31]. Despite their lack of increase after four weeks of 
AngII infusion in normal sodium fructose fed rats, TGF-β and SMAD2 may have been 
stimulated transiently during the initial phase of angiotensin II administration. An important 
finding of our transcriptomic analysis is that COL1A2 is downregulated in the heart of rats 
under low salt diet. This agrees with a study showing that a high salt diet in a mouse model of 
normotensive DOCA induced cardiac hypertrophy along with overexpression of COL1A2 
compared with the low salt diet [32]. To extend our transcriptomic analysis, we explored the 
expression of several genes involved in the inflammation process. Low sodium diet was 
associated with a downregulation of TNF-α and RELA, the p65 subunit of NFkB, which 
regulates the expression of several genes implicated in inflammation. The TNF pathway is a 
known negative regulator of COL1A2 expression, thus being antagonistic to TGF-β effects 
[33]. The fact that these pro- and anti-fibrotic cytokines are reduced by LS diet while a global 
downregulation of COL1A2 and a lower fibrosis are observed suggest a predominant effect of 
TGF-β over TNF-α in the context of a cardiometabolic disease. Altogether, these observations 
favor a modulation by dietary sodium intake of the TGF-β/SMAD signaling pathway, 
regulating collagen production in the heart.  
 
A major finding of this study is the downregulation of innate immunity related genes in the 
cardiac tissue of fructose rats when sodium was excluded from the diet. Transcriptomic 
analysis comparing LS and NS diets revealed differential regulation of 13 genes, several of 
them being involved in the so called “sterile inflammation”, a mechanism allowing sensing 
and reacting to non-microbial signals, through host receptors and endogenous molecules 
(DAMPs, Damage Associated Molecular Patterns) [34]. S100 calcium-binding proteins have 
been identified as DAMPs based on their ability to stimulate pro-inflammatory cytokine 
production. Particularly, S100A11 was found in normal cardiomyocytes, and its tissular 
expression was enhanced with myocardial damage [35]. S100A11 is a ligand of RAGE, the 
receptor for advanced glycation end products, and was shown to stimulate inflammation 
induced chondrocyte hypertrophy [36]. Moreover, RAGE is expressed on macrophages, and 
cardiac fibroblasts [37]. Here, both S100A11 and RAGE (Table 2 and Figure S3-S4) are 
downregulated in the heart of rats on low sodium diet, as simultaneously observed for TNF-α 
and RELA. Thus, S100A11 and its receptor RAGE could be implicated in sensing myocardial 
damage induced by high fructose and AngII, and their downregulation may be a mechanism 
through which low sodium diet prevents cardiac inflammation and damages.  
Three downregulated transcripts, hepcidin (HAMP), allograft inflammatory factor (AIF)-1 
and the tyrosine kinase FES, retained our attention because they are related to the innate 
immune receptors TLR2 and TLR4 (Toll Like Receptors), which are, along with RAGE, 
DAMPS receptors [34]. Hepcidin is an antimicrobial peptide induced in macrophages during 
inflammation. Hepcidin expression is induced following TLR2 and TLR4 activation in 
macrophages [38] and elevated levels were found in peripheral mononuclear cells from 
patients with diabetes and obesity [39]. Therefore, hepcidin can also be induced in chronic 
inflammatory states and represent another component of the innate immune response 
downregulated by LS diet.  
Allograph inflammatory factor is another immune-related gene that is downregulated in low 
sodium fed rats (Table 2, Figure S3). AIF1 was first identified in injured rat carotid arteries 
[40], and expressed by activated macrophages [41]. Its expression is reduced under anti-
inflammatory conditions in several models [42] and overexpressed in patients with cardiac 
allograft rejection [43]. Moreover, AIF1 was proposed as a significant predictor of activated 
macrophages in metabolic and cardiovascular diseases in humans [44]. AIF1 can be induced 
by TNF-α, and in turn, induces CCL2 expression and chemotaxis of peripheral blood 
mononuclear cells [45]. We believe this is the first time AIF1 is found to be downregulated in 
cardiac tissue in a hypertensive and insulin resistant rat model under a salt restrictive diet.  
The third transcript of interest is FES/FPS, a cytoplasmic tyrosine kinase involved in the 
regulation of innate immunity and inflammation. It acts by internalization and downregulation 
of the TLR4 receptor complex, leading to a reduced TNF-α secretion in macrophages via 
NFkB lowering as reported in Fes-/- mice [46]. Although the present observation of a 
downregulation of FES/FPS in LS rats may be surprising, it probably reflects a complex 
inflammation process where there is an imbalance between pro- and anti-inflammatory 
signals. Altogether, our results clearly demonstrate that salt restriction reduces cardiac 
damage in metabolic syndrome and suggest that the nutritional manoeuvre acts through the 
inhibition of innate immunity as proposed in Figure S6.  
Along with TLR2, RAGE and TLR4 are major putative sensors of DAMPs [34], and hence 
we investigated their mRNA expression in our model. TLR2, TLR4 and RAGE expression 
were unmodified by salt restriction. In the AngII infused rat, an upregulation of TNF-α and 
TLR2 mRNAs was observed in the kidney and of TLR4 and TNF-α in rat vascular smooth 
muscle cells [47]. We observe no change in TLR2 and TLR4 mRNA expression in left 
ventricles in our model (Table 2 and Figure S5, qPCR data); however, genes interacting with 
these receptors were all found downregulated by salt restriction, therefore much likely 
inhibiting related pathways.  
 
The transcriptomic data, confirmed with qPCR analysis and IHC, indicate that sodium 
withdrawal from the diet was associated with a lower recruitment of CD68 macrophages in 
cardiac tissue of fructose-fed rats. This was accompanied with a significant reduction of 
inflammatory genes, such as TNF-, RELA, and the chemokine CCL2, the latter allowing 
macrophage recruitment. A comparable effect was observed in the Dahl salt-sensitive/obese 
rat [19]. In the present study, the anti-inflammatory influence of sodium restriction was 
obtained in presence of two pro-inflammatory maneuvers, a nutritional (fructose feeding) and 
a hormonal (AngII) chronic exposure. In our previous study [25], fructose feeding was 
associated with a greater macrophage infiltration in the kidney and abdominal adipose tissue, 
an effect blunted by the LS diet. In the heart, a low grade inflammation was also observed in 
high-carbohydrate, high-fat fed rats [20]. On the other hand, monocytes/macrophages 
infiltration and inflammation have a role in the development of AngII mediated vascular 
injury [48].
 
 In the heart, AngII induced fibrosis through CCL2 and subsequent monocytes 
recruitment [49], and its hypertrophic effect was significantly attenuated in TNF- deficient 
mice [50]. Together with our present findings, these observations strongly suggest that 
reduction of macrophage recruitment and cardiac inflammation have an important role in the 
beneficial effect of sodium restriction on cardiac remodeling. Our work shows that a simple 
diet modification consisting in sodium reduction results in declined cardiac macrophage 
infiltration and consequent improvement of hypertension and cardiac damage. 
 
5 CONCLUSIONS 
Our data support the concept that innate immunity participates in the development of cardiac 
remodeling in metabolic syndrome. These findings support the rationale for further clinical 
studies to evaluate the potential benefit of dietary sodium reduction in patients with cardiac 
hypertrophy associated or not with insulin resistance and hypertension. Moreover, it will be 
important to determine whether changes in sodium consumption are associated with 
inflammatory and immune responses in this context. 
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FIGURE LEGENDS 
Figure 1: Influence of dietary sodium restriction on cardiac morphological and histological 
alterations. (2-column fitting image) 
A. Systolic tail-cuff pressure in rats fed high fructose diet with a NS (0.64%) or LS (<0.01%) 
content, prior to and at the end of the 4-week period of AngII infusion. B. Relative change 
from pre-AngII period. N=20 in each group. C. Representative microphotographs of 
hematoxylin-eosin staining of left ventricle tissue and quantitative analysis of cardiomyocyte 
area. D. The linear relationship between final body and heart weights was determined in all 
rats. The steepening of the slope observed in AngII, NS fructose rats compared to their 
controls (7.0x-1.5 vs 3.4x-0.3 HW/kg BW) was prevented in rats fed the LS diet (3.2x-0.1 vs 
3.3-0.2 g HW/kg BW for AngII-infused and their LS fructose controls, respectively). N=20 in 
each group. E. Representative microphotographs of Sirius red staining and quantitative 
analysis of collagen deposition (% stained area in left ventricular tissue). N=10 in each group. 
F. Cardiac expression of TGF- and SMAD2 evaluated by qPCR analysis and expressed 
relative to GAPDH mRNA. N=20 in each group. CT: control. Data are means ± SEM. 
*P<0.05 vs corresponding control group. 
 
Figure 2: Differentially expressed genes. (2-column fitting image) 
Histogram showing the 66 differentially expressed genes between NS and LS rats sorted by 
ontological category "Biological process". Diamonds represent fold enrichment when 
significant (P value <0.05). 
 
Figure 3: Infiltration of inflammatory cells in cardiac tissue. (2-column fitting image) 
A. Representative microphotographs of immunohistochemistry for CD68 in the left ventricle. 
Negative controls (NC) are shown in the smaller box. Quantification of CD68 positive 
macrophage infiltration is indicated in the histogram. B. Cardiac mRNA expression of CD68 
and CD11b evaluated by qPCR analysis and expressed relative to GAPDH mRNA content. 
N=10 in each group. C. Cardiac mRNA expression of TNF-α, RELA, CCR2 and CCL2 
evaluated by qPCR analysis and expressed relative to GAPDH mRNA content. NS and LS 
group includes control and AngII-infused animals, i.e. 20 rats in each group. Data are means ± 
SEM. 
  
Table 1: Influence of AngII infusion and low sodium diet on experimental parameters in 
fructose fed rats. 
Groups 
NS Fructose 
CT 
NS Fructose 
+AngII 
LS Fructose 
CT 
LS Fructose 
+AngII 
Final Body Weight (g) 4208 4188 3488† 3427† 
BW Change from week 4 (g) 56.73.0 60.04.4 38.69.5† 32.63.3† 
3-day mean food intake (g/24h, 
8
th
 week) 
20.30.7 21.60.6 17.80.5† 18.30.5† 
Heart Weight (g) 1.170.04 1.390.04* 0.980.03 1.020.07† 
Heart Weight Index (mg/gBW) 2.800.06 3.300.06* 2.780.03 3.000.07† 
LV Weight (g) 0.89±0.03 1.03±0.03* 0.70±0.02† 0.75±0.03† 
LV Weight Index (mg/gBW) 2.05±0.03 2.48±0.05* 2.07±0.04 2.17±0.05† 
Plasma glucose, mg/dL 123±7 125±4 127±4 120±4 
BW: Body Weight; LV: Left Ventricle. Data are mean  SE (n=20 per group). *p<0.05 vs. the 
respective control group; †p<0.05 vs. the corresponding NS Fructose group. 
 
22 
 
Table 2: Immune system transcripts that are differentially expressed between NS and LS rats. Microarray and qPCR validation data are shown. 
 
Gene symbol 
Microarray qPCR 
NCBI description 
Fold Change p value Corrected p Fold Change p value 
Fcgr3 -1,30 2,38E-04 9,43E-02 -1,35 2,60E-03 Fc fragment of IgG, low affinity IIa, receptor  
Fes -1,37 3,94E-04 9,43E-02 -1,17 2,30E-02 FES proto-oncogene, tyrosine kinase  
Tlr2 -1,39 2,03E-04 8,93E-02 -1,01 9,17E-01 Toll-like receptor 2  
C1qtnf6 -1,40 2,70E-04 9,43E-02 -1,02 7,68E-01 C1q and tumor necrosis factor related protein 6  
Scarb1 -1,43 7,62E-05 8,81E-02 -1,25 1,44E-02 Scavenger receptor class B, member 1  
Pi16 -1,44 1,54E-04 8,93E-02 -1,24 1,44E-02 Peptidase inhibitor 16 
Tpo -1,46 3,62E-04 9,43E-02 1,13 1,65E-01 Thyroid peroxidase 
C1qtnf9 -1,47 4,30E-04 9,43E-02 -1,50 3,91E-06 C1q and tumor necrosis factor related protein 9 
Col1a2 -1,50 4,13E-04 9,43E-02 -1,53 2,79E-05 Collagen, type I, alpha 2 
Aif1 -1,50 1,22E-04 8,81E-02 -1,25 1,75E-04 Allograft inflammatory factor 1 
S100a11 -1,52 7,35E-05 8,81E-02 -1,36 4,53E-07 S100 calcium binding protein A11 
Emr1 -1,57 1,12E-04 8,81E-02 -2,34 4,93E-05 Adhesion G protein-coupled receptor E1 
Hamp -2,42 4,97E-06 5,64E-02 -2,86 4,01E-07 Hepcidin antimicrobial peptide  
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Figure 1: Influence of dietary sodium restriction on cardiac morphological and histological 
alterations. 
A. Systolic tail-cuff pressure in rats fed high fructose diet with a NS (0.64%) or LS (<0.01%) 
content, prior to and at the end of the 4-week period of AngII infusion. B. Relative change 
from pre-AngII period. N=20 in each group. C. Representative microphotographs of 
hematoxylin-eosin staining of left ventricle tissue and quantitative analysis of cardiomyocyte 
area. D. The linear relationship between final body and heart weights was determined in all 
rats. The steepening of the slope observed in AngII, NS fructose rats compared to their 
controls (7.0x-1.5 vs 3.4x-0.3 HW/kg BW) was prevented in rats fed the LS diet (3.2x-0.1 vs 
3.3-0.2 g HW/kg BW for AngII-infused and their LS fructose controls, respectively). N=20 in 
each group. E. Representative microphotographs of Sirius red staining and quantitative 
analysis of collagen deposition (% stained area in left ventricular tissue). N=10 in each group. 
F. Cardiac expression of TGF- and SMAD2 evaluated by qPCR analysis and expressed 
relative to GAPDH mRNA. N=20 in each group. CT: control. Data are means ± SEM. 
*P<0.05 vs corresponding control group. 
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Figure 2: Differentially expressed genes. 
Histogram showing the 66 differentially expressed genes between NS and LS rats sorted by 
ontological category "Biological process". Diamonds represent fold enrichment when 
significant (P value <0.05). 
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Figure 3: Infiltration of inflammatory cells in cardiac tissue. 
A. Representative microphotographs of immunohistochemistry for CD68 in the left ventricle. 
Negative controls (NC) are shown in the smaller box. Quantification of CD68 positive 
macrophage infiltration is indicated in the histogram. B. Cardiac mRNA expression of CD68 
and CD11b evaluated by qPCR analysis and expressed relative to GAPDH mRNA content. 
N=10 in each group. C. Cardiac mRNA expression of TNF-α, RELA, CCR2 and CCL2 
evaluated by qPCR analysis and expressed relative to GAPDH mRNA content. NS and LS 
group includes control and AngII-infused animals, i.e. 20 rats in each group. Data are means ± 
SEM. 
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METHODS 
The present experiments complied with the European and French laws (permit numbers B-
3417226 and 34179) and conform to the Guide for the Care and Use of Laboratory Animals 
published by the National Institute of Health (National Academies Press US, 8th edition, 
2011). Rats were housed in climate controlled conditions with a 12h light/dark cycle in a 
room temperature-controlled (22±1°C). 
 
Animals and diets.  
Sprague-Dawley rats (Charles River, 180-200g) were fed for 8 weeks 60% fructose diet with 
either a normal sodium (0.64% NaCl) or a low sodium content (<0.01% NaCl) (n=40 in each). 
Four weeks after the beginning of the 60% fructose diet, twenty rats from each regimen were 
infused subcutaneously (osmotic pump Alzet 2004) with angiotensin II (AngII) at the dose of 
200 ng.kg
-1
.min
-1
 for the remaining four weeks. The other half was submitted to the same 
surgery without pump implantation.  
 
Blood pressure and glucose metabolism. 
In all rats, systolic blood pressure was measured in conscious animals using the tail-cuff 
method (Narco Biosystems INC), prior to and two days before the end of angiotensin II 
infusion, i.e. at week 4 and 8 of the fructose diet. The day after pressure measurement, rats 
were fasted (5h) to perform the insulin tolerance test (ITT). Glucose was measured in tail 
blood before and every 10 minutes for 90 minutes after an injection of lispro insulin (0.6U kg
-
1
 intraperitoneal,
 
Humalog, Lilly). Results are shown in supplementary data, figure S1. 
At the end of the experiment (8 weeks), rats were anaesthetized (pentobarbital, 60mg.kg
-1
, IP) 
and the heart was excised and rinsed. Large vessels and surrounding epicardial fat were 
carefully removed. The left ventricle (LV) including septum was weighed separately. Heart 
2 
 
and LV weight to body weight ratios were calculated as index of cardiac (HWI) and LV 
(LVWI) hypertrophy respectively. 
 
Cardiac histology and morphology. 
Half of the 20 rats from the four experimental groups served for cardiac histological and 
morphological determination. The LV was paraffin embedded, and 3-5 µm slices were cut for 
histological analysis. After haematoxylin-eosin coloration, the cardiomyocyte size was 
determined through measurement of the shortest transverse diameter in 30 transverse sections 
per heart. Collagen volume fraction was determined after by Sirius red staining, as previously 
described
1
. CD68 staining was used as a marker of rat macrophages and determined in LV 
tissues, as previously described
2
. 
 
RNA extraction, Microarray and statistical data analysis 
Microarray analysis was performed on cardiac tissue of twelve rats on the NS and LS fructose 
diets (n=6 in each), three animals taken in both control and AngII groups. Immediately after 
anaesthesia, the heart was collected, cleaned and weighed, and left ventricle samples were 
frozen in RNAlater® solution (Life Technologies). Tissues were then dissociated in RLT 
buffer using a Fast-Prep® homogeneizer (MP Biomedicals). Total RNA was extracted using 
RNeasy® Fibrous Tissue mini-kit (Qiagen). RNA quality and integrity were determined using 
the Agilent 2100 Bioanalyser (Agilent Technologies). 
For microarray experiments, sample treatment was performed as described using “one color 
microarray-based gene expression analysis” protocol (version 6.7, part number G4140-
90040). Briefly, 200ng of each total RNA samples (N=12) was used for amplification and 
labelling with the Agilent Low Input Quick amp Labelling kit, one color. Yields of cRNA and 
dye incorporation rate were measured using ND-1000 spectrometer (NanoDrop technologies, 
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Peqlab biotechnologies GmbH, Erlangen, Germany). Hybridization procedure was performed 
using Agilent Gene Expression Hybridization kit. Briefly, 1.65g Cy3-labeled fragmented 
cRNA was hybridized 17h at 65°C to Agilent Rat Gene Expression Microarray V3 4x44K 
using recommended manufacturer’s hybridization chambers and oven. The microarrays were 
then washed once with the Agilent Gene Expression Wash Buffer for 1 min at RT, and then 
washed with Agilent Gene Expression Wash buffer 2 at 37°C for 1 min. 
Fluorescence signals were detected using Agilent’s Microarray Scanner System and the 
Agilent Feature Extraction Software (version 11.0.1.1) to read out and process the microarray 
image files. 
The microarray data have been deposited in NCBI’s Gene Expression Omnibus3 and are 
accessible through GEO series accession number GSE84524. 
Statistical analysis was performed using R software version 3.3.0
4
 along with the Limma 
package
5
. The method used for background correction was based on the normal-exponential 
convolution model with the saddle-point approximation to maximum likelihood
6
. 
Normalization was performed using cyclic loess
7
 method. Only probes whose signal was 
considered as higher than background in at least four out of six replicates in at least one 
condition were selected for further analysis. Within-array replicate probes were replaced with 
their average. The assessment of differentially expressed mRNAs between NS diet and LS 
diet was performed using the limma GLM (Generalized Linear Model) method followed by 
Benjamini Hochberg correction for multiple testing. Genes with a corrected p-value lower 
than 0.1 were selected for further investigation.   
 
Gene Ontology (GO) enrichment analysis 
The genes symbols of significantly differentially expressed genes were matched with GO 
terms using gene annotations for the organism Rattus norvegicus in terms of biological 
4 
 
process, molecular function and cellular component (www.geneontology.org). GO terms 
enrichment analysis of these genes was performed. To this end, a binomial test was applied to 
determine whether there is a statistical overrepresentation or underrepresentation of the genes 
in our test list relative to the reference list (rat genome). A P value was calculated to 
determine whether the over- or underrepresentation is significant or not (p<0.05 considered 
significant)
8
. 
 
RNA isolation, reverse transcription, and real-time quantitative PCR analysis.  
The second half (N=10) of rats from each group was used for transcript analysis. Immediately 
after anaesthesia, the heart was collected, cleaned and weighed, and left ventricle samples 
were frozen in RNAlater® solution (Life Technologies). Tissues were then dissociated in 
RLT buffer using a Fast-Prep® homogeneizer (MP Biomedicals). Total RNA was extracted 
using RNeasy® Fibrous Tissue mini-kit (Qiagen). Complementary DNA was synthesized 
using Omniscript® reverse transcriptase (Life Technologies). Real-time quantitative PCR was 
done with the use of the LC480 real time PCR instrument (Roche). Primer pairs were 
generated using NCBI primer design application and were designed to span an exon-exon 
junction. Forward and reverse primers sequences are shown in table S1 and were used at a 
60°C annealing temperature. Data on gene expression were normalized according to data 
from Gapdh housekeeping gene.  
 
Western Blotting 
Snap frozen left ventricles from fructose+AngII NS (n=3) and LS (n=3) rats were dissociated 
in RIPA buffer (Abcam) using a Fast-Prep® homogeneizer (MP Biomedicals). Total proteins 
were quantified using BCA assay (Pierce). Western blotting was performed using antibodies 
as follows: anti-AIF-1 (Abcam, ab178847), anti-Hepcidin-25 (Abcam, ab187778), anti-
5 
 
S100A11 (Abcam, ab180593), anti-GAPDH (Santa Cruz, sc-25778). The secondary antibody 
was an anti-rabbit antibody from Millipore (AP188P). 
 
Statistical analysis.  
Quantitative PCR results are expressed as the mean ± SEM. The statistical evaluation was 
performed using two-factor analysis of variance (ANOVA) and post hoc comparisons were 
performed by means of Fisher’s Protected Least Significant Differences (PLSD) test. If the 
data were not normally distributed, statistical evaluation was performed by using ANOVA 
(Kruskall-Wallis) and Mann-Whitney U test. Differences were considered significant when 
p< 0.05. 
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Table S1: primer pairs used for qPCR 
Name Forward primer Reverse primer 
EMR1 5’-GCCATAGCCACCTTCCTGTT-3’ 5’-ATAGCGCAAGCTGTCTGGTT-3’ 
S100A11 5’-CATCGAGTCCCTGATTGCTGT-3’ 5’-GGGTCCTTCTGGTTCTTCGTG-3’ 
TLR2 5’-GAGGTCTCCAGGTCAAATCTCAG-3’ 5’-ACACACCAGCAGCATCACAT-3’ 
TLR4 5’-CTCTGCCCTGCCACCATTTA-3’ 5’-AGGAAGTACCTCTATGCAGGGAT-3’ 
FES 5’-GCCAGCAAAGACAAGGATCG-3’ 5’-AGTACGTAGCGGTTGTGGTG-3’ 
PI16 5’-AGAGAATCGGCTGTGGTTCC-3’ 5’-GGTTTTCTCTCCGGCTCACA-3’ 
TPO 5’-TCCACGGATGCACTATCAGC-3’ 5’-TTGCTAGGGCTGTGTTGGAG-3’ 
AIF1 5’-TCATCGTCATCTCCCCACCT-3’ 5’-GCTTTTCCTCCCTGCAAATCC-3’ 
SCARB1 5’-AGGTGCTCAAGAATGTCCGC-3’ 5’-CATTTAGGACCTCGCTGGGG-3’ 
C1QTNF6 5’-TCCTCTTGTGTTTGGGGTCC-3’ 5’-CCCTTTGTCACCTTTCAGGATG-3’ 
C1QTNF9 5’-AGACACAGGAGAACCAGGACAT-3’ 5’-ACCTCGCCTTTATCCCCCTT-3’ 
FCGR2A 5’-CTGAAGGGCTCCGGTTCG-3’ 5’-GTCTAGGAGATGAACTGCTGGC-3’ 
HAMP 5’-AGATGGCACTAAGCACTCGG-3’ 5’-CCGTAGTCTGTCTCGTCTGTT-3’ 
COL1A2 5’-TGTCGATGGCTGCTCCAAAA-3’ 5’-CCGATGTCCAGAGGTGCAAT-3’ 
RAGE 5’-TTCCTGATGGCAAAGGGACA-3’ 5’-CTGACCGAAGCGTGAAGAGT-3’ 
CD68 5’-CGCATCTTGTACCTGACCCA-3’ 5’-AGAATGTCCACTGTGCTGCTT-3’ 
CD11b 5’-TTGCCTAGGGGGAGAGCAC- 3’ 5’-GCTGGCTACTGATGCTCCAT- 3’ 
TNF-α 5’-GTAGCCCACGTCGTAGCAAA-3’ 5’-AAATGGCAAATCGGCTGACG-3’ 
RELA 5’-CATACGCTGACCCTAGCCTG-3’ 5’-CGGGGTTCAGTTGGTCCATT-3’ 
CCL2 5’-TGTCTCAGCCAGATGCAGTT-3’ 5’-CAGCCGACTCATTGGGATCA-3’ 
CCR2 5’-TAGGGCTGTGAGGCTCATCT-3’ 5’-GCTCCCCAGTAGAAGGGGTA-3’ 
TGF-β 5’-CTGGAAAGGGCTCAACACCT-3’ 5’-CTTCTCTGTGGAGCTGAAGCA-3’ 
SMAD2 5’-TCCATCTTGCCATTCACTCCG-3’ 5’-GAGCAAGTGCTTGGTATGGTGA-3’ 
GP91PHOX 5’-AGACTGGACTGAGGGGCTAT-3’ 5’-CAGGTCTGCGAACCACTCAA-3’ 
GAPDH 5’-ACTTTGGCATCGTGGAAGGG-3’ 5’-ACTTGGCAGGTTTCTCCAGG-3’ 
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Figure S1: Insulin sensitivity in rats fed high fructose diet with a normal sodium (NS 0.64%) 
or low sodium (LS<0.01%) content. A: Change in glycaemia during the insulin tolerance test 
at the end of the 4-week period of angiotensin II infusion. B: Area under the curve (AUC) of 
glycaemia response during the insulin tolerance test (ITT). N=20 in each group. Data are 
means ± SEM. * P<0.05 compared to the NS Fructose control group. 
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Figure S2: Boxplot of differentially expressed genes involved in immunological process. 
(Fcgr3=Fcgr2a) 
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Figure S3: Cardiac expression of AIF1, HAMP and S100A11 by immunoblot. GAPDH 
expression was used as a control. 
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Figure S4: Cardiac mRNA expression of S100A11 and RAGE evaluated by qPCR. Data are 
mean ± SEM. 
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Figure S5: Cardiac mRNA expression of TLR4 evaluated by qPCR. Data are mean ± SEM. 
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Figure S6: Network depicting gene products differentially regulated in the heart of rats in our 
model of metabolic syndrome. Documented and possible relationships between them are 
indicated. 
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